Cita APA

Bourgonje, A. R., Kloska, D., Grochot-Przeczek, A., Feelisch, M., Cuadrado, A., & Goor, H. v. (2023). Personalized redox medicine in inflammatory bowel diseases: An emerging role for HIF-1α and NRF2 as therapeutic targets.

Citación estilo Chicago

Bourgonje, Arno R., Damian Kloska, Anna Grochot-Przeczek, Martin Feelisch, Antonio Cuadrado, y Harry van Goor. Personalized Redox Medicine in Inflammatory Bowel Diseases: An Emerging Role for HIF-1α and NRF2 As Therapeutic Targets. 2023.

Cita MLA

Bourgonje, Arno R., et al. Personalized Redox Medicine in Inflammatory Bowel Diseases: An Emerging Role for HIF-1α and NRF2 As Therapeutic Targets. 2023.